OpenCompanies

Viridian Therapeutics Europe Limited

Company number
07543968
Status
Active
Type
Private Limited Company
Incorporated
25 Feb 2011
Nature of business
Research and experimental development on biotechnology

Registered office

Cannon Place, 78
Cannon Street
London
EC4N 6AF

Previous names

  • Miragen Therapeutics Europe Limited (until 18 Feb 2021)
  • Newincco 1092 Limited (until 17 May 2011)

Officers

NameRoleAppointedResigned
HARMON, Seth Thomas Director 26 Nov 2024
TOUSIGNANT, Jennifer Dianne Director 26 Nov 2024
BEETHAM, Thomas William Director 1 Nov 2023
OLSWANG COSEC LIMITED Corporate-Secretary 25 Feb 2011 1 Apr 2024
HARMON, Seth Director 12 Nov 2024 1 Nov 2023
HUMER, Kristian Director 11 Apr 2022 12 Sep 2023
LEVERONE, Jason Alan Director 5 Oct 2020 11 Apr 2022
MARSHALL, William Stuart Director 26 May 2011 4 Oct 2020
MACKIE, Christopher Alan Director 25 Feb 2011 26 May 2011
OLSWANG DIRECTORS 1 LIMITED Corporate-Director 25 Feb 2011 26 May 2011
OLSWANG DIRECTORS 2 LIMITED Corporate-Director 25 Feb 2011 26 May 2011

Control

NameNature of controlNotifiedCeased
Viridian Therapeutics, Inc. Ownership Of Shares 75 To 100 Percent
Voting Rights 75 To 100 Percent
Right To Appoint And Remove Directors
6 Apr 2016

Accounts

Year ended Net assets Cash Employees
31 Dec 2025 Dormant £20 - 0
28 Feb 2025 £20 - 0
29 Feb 2024 £20 - 0
28 Feb 2023 £20 - 0
28 Feb 2022 Dormant £1 £1 -
28 Feb 2021 Dormant £1 £1 -
29 Feb 2020 Dormant £1 £1 -
28 Feb 2019 Dormant £1 £1 -
28 Feb 2018 Dormant £1 £1 -
28 Feb 2017 Dormant £1 £1 -
29 Feb 2016 Dormant £1 £1 -
28 Feb 2015 Dormant £1 £1 -
28 Feb 2014 Dormant £1 £1 -
28 Feb 2013 Dormant £1 £1 -
29 Feb 2012 Dormant £1 £1 -

Connections

Companies at the same address

Data